PharmaLegacy Laboratories Acquires San Diego-Based BTS Research
September 16, 2024
PharmaLegacy Laboratories has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO), expanding PharmaLegacy's in vitro and in vivo pharmacology and GLP toxicology capabilities. The acquisition gives PharmaLegacy a local presence in San Diego to increase study capacity and support clients across the United States and North America.
- Buyers
- PharmaLegacy Laboratories
- Targets
- BTS Research
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Flagship Facility Services Acquires Biotechnical Services (BTS)
April 17, 2023
Healthcare Services
Flagship Facility Services has acquired Biotechnical Services, Inc. (BTS), a San Diego-based independent laboratory services company that provides equipment repair, calibration, and maintenance to biotech clients. BTS will join Flagship Lab Services to expand Flagship's biotech/lab services capabilities and offer enhanced equipment support and asset management to clients nationwide.
-
Labcorp Acquires Toxikon Corporation
November 18, 2021
Healthcare Services
Labcorp has acquired Toxikon Corporation, a Bedford, Massachusetts-based contract research organization that provides nonclinical in vivo and in vitro testing for pharmaceutical, biotech and medical device clients. The acquisition expands Labcorp Drug Development's nonclinical testing capabilities and creates a strategic Boston-area footprint; Toxikon reported approximately $40 million in annual revenue and the deal closed in December 2021.
-
Discovery Life Sciences Acquires ReachBio Research Labs
April 11, 2023
Biotechnology
Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.
-
Velocity Clinical Research Acquires MedPharmics
September 7, 2022
Healthcare Services
Velocity Clinical Research, a portfolio company of GHO Capital, has acquired MedPharmics, a U.S.-based multi-site clinical research organization. The add-on expands Velocity's network by eight sites (bringing it to 40 locations), adds just over 100 employees, and improves access to diverse patient populations including African American and Native American communities.
-
Nutra-Med Acquires Legacy Pharma Solutions
October 22, 2024
Manufacturing
Nutra-Med, a portfolio company of GenNx360 Capital Partners, has acquired Legacy Pharma Solutions, a St. Louis-based provider of oral solid dose contract packaging. The acquisition adds high-speed bottling and blistering capabilities to Nutra-Med, expanding its contract packaging capacity for pharmaceutical, OTC and medical device customers.
-
L2P Research Acquires METIS Research Laboratories
February 28, 2020
Biotechnology
L2P Research, LLC has acquired METIS Research Laboratories, a Ronkonkoma, New York-based preclinical CRO that provides radiotracer, radioligand binding, ADME/PK and QWBA services. The acquisition adds a GLP-compliant 5,000 sq. ft. facility and expands L2P's preclinical capabilities for pharma, biotech and academic customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.